Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation (vol 5, pg 285, 2004)

被引：15
|
作者：
Durie, BGM
Kyle, RA
Belch, A
Bensinger, W
Blade, J
Boccadoro, M
Child, JA
Comenzo, R
Djulbegovic, B
Fantl, D
Gahrton, G
Harousseau, JL
Hungria, V
Joshua, D
Ludwig, H
Mehta, J
Morales, AR
Morgan, G
Nouel, A
Oken, M
Powles, R
Roodman, D
San Miguel, J
Shimizu, K
Singhal, S
Sirohi, B
Sonneveld, P
Tricot, G
Van Ness, B
机构：
来源：
HEMATOLOGY JOURNAL | 2004年 / 5卷 / 03期
关键词：
D O I：
10.1038/sj.thj.6200402
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [1] Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group
    Raje, Noopur S.
    Anaissie, Elias
    Kumar, Shaji K.
    Lonial, Sagar
    Martin, Thomas
    Gertz, Morie A.
    Krishnan, Amrita
    Hari, Parameswaran
    Ludwig, Heinz
    O'Donnell, Elizabeth
    Yee, Andrew
    Kaufman, Jonathan L.
    Cohen, Adam D.
    Garderet, Laurent
    Wechalekar, Ashutosh F.
    Terpos, Evangelos
    Khatry, Navin
    Niesvizky, Ruben
    Yi, Qing
    Joshua, Douglas E.
    Saikia, Tapan
    Leung, Nelson
    Engelhardt, Monika
    Mothy, Mohamad
    Branagan, Andrew
    Chari, Ajai
    Reiman, Anthony J.
    Lipe, Brea
    Richter, Joshua
    Rajkumar, S. Vincent
    San Miguel, Jesus
    Anderson, Kenneth C.
    Stadtmauer, Edward A.
    Prabhala, Rao H.
    McCarthy, Phillip L.
    Munshi, Nikhil C.
    [J]. LANCET HAEMATOLOGY, 2022, 9 (02): : E143 - E161
  • [2] Survivorship Care Guidelines for Patients Living With Multiple Myeloma: Consensus Statements of the International Myeloma Foundation Nurse Leadership Board
    Bilotti, Elizabeth
    Faiman, Beth M.
    Richards, Tiffany A.
    Tariman, Joseph D.
    Miceli, Teresa S.
    Rome, Sandra I.
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2011, 15 (04) : 5 - 8
  • [3] Guidance for Use and dosing of Selinexor in Multiple Myeloma in 2021: Consensus From International Myeloma Foundation Expert Roundtable
    Nooka, A. K.
    Costa, L. J.
    Gasparetto, C. J.
    Richardson, P. G.
    Siegel, D. S.
    Chari, A.
    Lentzsch, S.
    Jagannath, S.
    Mikhael, J.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (07): : E526 - E531
  • [4] Management of side effects of novel therapies for multiple myeloma: Consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board
    Bertolotti, Page
    Bilotti, Elizabeth
    Colson, Kathleen
    Curran, Kathleen
    Doss, Deborah
    Faiman, Beth
    Gavino, Maria
    Jenkins, Bonnie
    Lilleby, Kathy
    Love, Ginger
    Mangan, Patricia A.
    McCullagh, Emily
    Miceli, Teresa
    Miller, Kena
    Rogers, Kathryn
    Rome, Sandra
    Sandifer, Stacey
    Smith, Lisa C.
    Tariman, Joseph D.
    Westphal, Jeanne
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (03) : 9 - 12
  • [5] Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013 (vol 88, pg 360, 2013)
    Stewart, A. Keith
    [J]. MAYO CLINIC PROCEEDINGS, 2013, 88 (07) : 777 - 777
  • [6] Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
    Lin, Yi
    Qiu, Lugui
    Usmani, Saad
    Joo, Chng Wee
    Costa, Luciano
    Derman, Benjamin
    Du, Juan
    Einsele, Hermann
    de Larrea, Carlos Fernandez
    Hajek, Roman
    Ho, P. Joy
    Kastritis, Efstathios
    Martinez-Lopez, Joaquin
    Mateos, Maria-Victoria
    Mikhael, Joseph
    Moreau, Philippe
    Nagarajan, Chandramouli
    Nooka, Ajay
    O'Dwyer, Michael
    Schjesvold, Fredrik
    Sidana, Surbhi
    van de Donk, Niels W. C. J.
    Weisel, Katja
    Zweegman, Sonja
    Raje, Noopur
    Otero, Paula Rodriguez
    Anderson Jr, Larry D.
    Kumar, Shaji
    Martin, Tom
    [J]. LANCET ONCOLOGY, 2024, 25 (08): : e374 - e387
  • [7] International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma (vol 17, pg e328, 2016)
    Kumar, S.
    Paiva, B.
    Anderson, K. C.
    [J]. LANCET ONCOLOGY, 2016, 17 (09): : E373 - E373
  • [8] Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report (vol 125, pg 2068, 2015)
    Palumbo, A.
    Bringhen, S.
    Mateos, M-, V
    [J]. BLOOD, 2016, 128 (07) : 1020 - 1020
  • [9] Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report (vol 125, pg 2068, 2015)
    Palumbo, A.
    Bringhen, S.
    Mateos, M-, V
    [J]. BLOOD, 2016, 127 (09) : 1213 - 1213
  • [10] Treatment of patients with Waldenstrom macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group
    Talaulikar, Dipti
    Tam, Constantine S.
    Joshua, Douglas
    Ho, Joy Phoebe
    Szer, Jeff
    Quach, Hang
    Spencer, Andrew
    Harrison, Simon
    Mollee, Peter
    Roberts, Andrew W.
    Horvath, Noemi
    Lee, Cindy
    Zannettino, Andrew
    Brown, Ross
    Augustson, Bradley
    Jaksic, Wilfrid
    Gibson, John
    Kalff, Anna
    Johnston, Anna
    Trotman, Judith
    Kalro, Akash
    Grigoriadis, George
    Ward, Chris
    Prince, H. Miles
    [J]. INTERNAL MEDICINE JOURNAL, 2017, 47 (01) : 35 - 49
12345